75 REP 9AC IS A POTENT HBSAGRELEASE INHIBITOR WHICH CLEARS SERUM HBSAG AND ELICITS SVRS IN PATIENTS WITHCHRONIC HEPATITIS B
Journal of Hepatology, Volume 54, Supplement 1, March 2011,Page S34 M. Al-Mahtab, M. Bazinet, A. Vaillant Therapeutic Efficacy of the Amphipathic DNA Polymer REP 9AC in the Treatment of Duck Hepatitis B Virus InfectionIn Vivo
Antiviral Research, Volume 82, Issue 2, May 2009, PagesA30-A31
Faseeha Nordeen, Arend Grosse, Jean-Marc Juteau, Andrew Vaillant, AllisonJilbert Preclinical Development of the Amphipathic DNA Polymer REP 9AC for the Treatment of Hepatitis B Virus Infection
Antiviral Research, Volume 78, Issue 2, May 2008, PageA25
Faseeha Noordeen, Andrew Vaillant, Jean-Marc Juteau, Allison Jilbert 1002 PHARMACOKINETIC STUDIES ON A NOVEL HBV ENTRYINHIBITOR MYRCLUDEX B DEMONSTRATE HBV-RECEPTOREXPRESSION IN RODENTS AND DOGS BUT NOT IN CYNOMOLGUS MONKEYS
Journal of Hepatology, Volume 52, Supplement 1, April 2010,Page S387
A. Schieck, A. Meier, A. Alexandrov, C. Leder, P. Romeis, U. Haberkorn, W. Mier, S. Urban 10 PRECLINICAL STUDIES ON MYRCLUDEXB, A NOVEL ENTRY INHIBITOR FOR HEPATITS B- AND HEPATITIS DELTA VIRUS (HDV)INFECTIONS
Journal of Hepatology, Volume 52, Supplement 1, April 2010,Page S5
S. Urban, A. Schulze, A. Schieck, C. Gähler, Y. Ni, A. Meier, A. Alexandrov, W.Mier 73 ADMINISTRATION OF THE ENTRY INHIBITOR MYRCLUDEX-B AFTER ESTABLISHMENT OF HEPATITIS B VIRUSINFECTION PREVENTS VIRAL SPREADING AMONG HUMAN HEPATOCYTES IN UPA MICE
Journal of Hepatology, Volume 54, Supplement 1, March 2011,Page S33
M. Ben M'Barek, T. Volz, M. Lutgehetmann, T. Bornscheuer, L. Allweiss, A.W.Lohse, A. Alexandrov, S. Urban, J. Petersen, M. Dandri 105 BLOCK OF HEPATITIS DELTA INFECTION BY THE ENTRYINHIBITOR MYRCLUDEX B IN UPA MICE: ESTABLISHMENT OF ANEFFICIENT MOUSE MODEL FOR HUMAN HBV/HDV INFECTION
Journal of Hepatology, Volume 54, Supplement 1, March 2011,Page S47
M. Lutgehetmann, L.V. Mancke, L. Allweiss, T. Volz, M. Helbig, A.W. Lohse, A.Alexandrov, J. Petersen, S. Urban, M. Dandri | 
发表于 2011-7-19 11:43
